戻る Agenda
Session 9 Plenary: Health Canada Town Hall
Session Chair(s)
Katalin Bertenyi, MSc
Manager, Centre for Blood, Blood Products and Biotherapeutics, Health Canada, Canada
Adesola Adeyemi, MSc
Regulatory Affairs Project Manager, Bayer Inc., Canada
In this session, leaders from Health Canada will provide updates on regulatory priorities and on current and future initiatives. Attendees will gain insights into upcoming changes in policies, emerging guidance documents and evolving initiatives. Health Canada speakers will answer questions related to key policy and regulatory initiatives.
Learning Objective : At the conclusion of this session, participants should be able to: - Describe Health Canada’s current regulatory priorities and strategic initiatives
- Identify upcoming policy changes, emerging guidance and evolving initiatives
- Identify opportunities to engage with Health Canada regulators
Speaker(s)
Representative Invited
Director General, Pharmaceutical Drugs Directorate, Health Canada, Canada
Speaker
Representative Invited
Director General, Policy, Planning and International Affairs Directorate, HPFB, Health Canada, Canada
Speaker
Sonia Corrent
Director General, Biologic and Radiopharmaceutical Drugs Directorate, Health Canada, Canada
Speaker